Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589019 | SCV000698639 | uncertain significance | not provided | 2017-02-06 | criteria provided, single submitter | clinical testing | Variant summary: : The SOS1 c.3857C>G (p.Ser1286Cys) variant involves the alteration of a conserved nucleotide and is predicted to be damaging by 3/5 in silico tools. The variant is located outside of some commonly known domains in the SOS1 protein (InterPro). This variant is absent in 121374 control chromosomes from ExAC. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories, nor evaluated for functional impact by in vivo/vitro studies. Another missense variant in the same residue, p.Ser1286Phe, has been classified as likely benign by a clinical lab in CinVar. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available. |
Ai |
RCV000589019 | SCV002503481 | uncertain significance | not provided | 2020-07-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002467912 | SCV002763187 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467911 | SCV002763189 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |